129 related articles for article (PubMed ID: 29411649)
1. Alteration in microRNA-155 level correspond to severity of coronary heart disease.
Qiu XK; Ma J
Scand J Clin Lab Invest; 2018 May; 78(3):219-223. PubMed ID: 29411649
[TBL] [Abstract][Full Text] [Related]
2. Association between elevated plasma microRNA-223 content and severity of coronary heart disease.
Guo JF; Zhang Y; Zheng QX; Zhang Y; Zhou HH; Cui LM
Scand J Clin Lab Invest; 2018 Sep; 78(5):373-378. PubMed ID: 29888618
[TBL] [Abstract][Full Text] [Related]
3. Association between circulating microRNA-208a and severity of coronary heart disease.
Zhang Y; Li HH; Yang R; Yang BJ; Gao ZY
Scand J Clin Lab Invest; 2017 Sep; 77(5):379-384. PubMed ID: 28554251
[TBL] [Abstract][Full Text] [Related]
4. Interaction between microRNA expression and classical risk factors in the risk of coronary heart disease.
Ding XQ; Ge PC; Liu Z; Jia H; Chen X; An FH; Li LH; Chen ZH; Mao HW; Li ZY; Gu Y; Zhu TB; Li CJ; Wang LS; Ma WZ; Yang ZJ; Jia EZ
Sci Rep; 2015 Oct; 5():14925. PubMed ID: 26446730
[TBL] [Abstract][Full Text] [Related]
5. Increased alpha-defensin expression is associated with risk of coronary heart disease: a feasible predictive inflammatory biomarker of coronary heart disease in hyperlipidemia patients.
Maneerat Y; Prasongsukarn K; Benjathummarak S; Dechkhajorn W; Chaisri U
Lipids Health Dis; 2016 Jul; 15():117. PubMed ID: 27430968
[TBL] [Abstract][Full Text] [Related]
6. Circulating miRNA-33: a potential biomarker in patients with coronary artery disease.
Reddy LL; Shah SAV; Ponde CK; Rajani RM; Ashavaid TF
Biomarkers; 2019 Feb; 24(1):36-42. PubMed ID: 30022694
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNA-33b levels are associated with the presence and severity of coronary heart disease.
Chen C; Liu Q; Li Y; Yu JW; Wang SD; Xu JL; Liu L
Scand J Clin Lab Invest; 2024 Apr; 84(2):133-137. PubMed ID: 38597780
[TBL] [Abstract][Full Text] [Related]
8. Circulating MiR-146a May be a Potential Biomarker of Coronary Heart Disease in Patients with Subclinical Hypothyroidism.
Quan X; Ji Y; Zhang C; Guo X; Zhang Y; Jia S; Ma W; Fan Y; Wang C
Cell Physiol Biochem; 2018; 45(1):226-236. PubMed ID: 29357324
[TBL] [Abstract][Full Text] [Related]
9. The LDL-cholesterol to HDL-cholesterol ratio and the severity of coronary and aortic atherosclerosis.
Momiyama Y; Ohmori R; Fayad ZA; Tanaka N; Kato R; Taniguchi H; Nagata M; Ohsuzu F
Atherosclerosis; 2012 Jun; 222(2):577-80. PubMed ID: 22516791
[No Abstract] [Full Text] [Related]
10. The apoB100/apoAI ratio is independently associated with the severity of coronary heart disease: a cross sectional study in patients undergoing coronary angiography.
Song Y; Yang Y; Zhang J; Wang Y; He W; Zhang X; Zhu J; Lu Z
Lipids Health Dis; 2015 Nov; 14():150. PubMed ID: 26582246
[TBL] [Abstract][Full Text] [Related]
11. microRNA-155 is inversely associated with severity of coronary stenotic lesions calculated by the Gensini score.
Zhu GF; Yang LX; Guo RW; Liu H; Shi YK; Ye JS; Yang ZH
Coron Artery Dis; 2014 Jun; 25(4):304-10. PubMed ID: 24525789
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNA-378 levels serve as a novel biomarker for assessing the severity of coronary stenosis in patients with coronary artery disease.
Li H; Gao F; Wang X; Wu J; Lu K; Liu M; Li R; Ding L; Wang R
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31064817
[No Abstract] [Full Text] [Related]
13. Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease.
Gao W; He HW; Wang ZM; Zhao H; Lian XQ; Wang YS; Zhu J; Yan JJ; Zhang DG; Yang ZJ; Wang LS
Lipids Health Dis; 2012 May; 11():55. PubMed ID: 22587332
[TBL] [Abstract][Full Text] [Related]
14. Predictive Effects of Circulating miR-221, miR-130a and miR-155 for Coronary Heart Disease: A Multi-Ethnic Study in China.
Jia QW; Chen ZH; Ding XQ; Liu JY; Ge PC; An FH; Li LH; Wang LS; Ma WZ; Yang ZJ; Jia EZ
Cell Physiol Biochem; 2017; 42(2):808-823. PubMed ID: 28628920
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of Lipoprotein(a)-Containing Circulating Immune Complexes as Markers of Coronary Heart Disease.
Klesareva EA; Afanas'eva OI; Donskikh VV; Adamova IY; Pokrovskii SN
Bull Exp Biol Med; 2016 Dec; 162(2):231-236. PubMed ID: 27905032
[TBL] [Abstract][Full Text] [Related]
16. Relation of circulating lncRNA GAS5 and miR-21 with biochemical indexes, stenosis severity, and inflammatory cytokines in coronary heart disease patients.
Jiang Y; Du T
J Clin Lab Anal; 2022 Feb; 36(2):e24202. PubMed ID: 34997773
[TBL] [Abstract][Full Text] [Related]
17. Association of circulating microRNA-122 with presence and severity of atherosclerotic lesions.
Wang YL; Yu W
PeerJ; 2018; 6():e5218. PubMed ID: 30013851
[TBL] [Abstract][Full Text] [Related]
18. Significance of small dense low-density lipoprotein-cholesterol concentrations in relation to the severity of coronary heart diseases.
Koba S; Hirano T; Ito Y; Tsunoda F; Yokota Y; Ban Y; Iso Y; Suzuki H; Katagiri T
Atherosclerosis; 2006 Nov; 189(1):206-14. PubMed ID: 16414053
[TBL] [Abstract][Full Text] [Related]
19. MiR-17-5p as circulating biomarkers for the severity of coronary atherosclerosis in coronary artery disease.
Chen J; Xu L; Hu Q; Yang S; Zhang B; Jiang H
Int J Cardiol; 2015 Oct; 197():123-4. PubMed ID: 26134369
[No Abstract] [Full Text] [Related]
20. [The influence of statin therapy on circulating microRNA-92a expression in patients with coronary heart disease].
Wang H; Lu HM; Yang WH; Luo C; Lu SH; Zhou Y; Lin YZ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Apr; 24(4):215-8. PubMed ID: 22464573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
